Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team
Third party research

Cavotec: So far so good, but not done yet - ABG

Cavotec Group

This is a third party research report and does not necessarily reflect our views or values

Download report (PDF)
Report out 25 April at 07.00 CEST
Q1e sales of EUR 45m +4% y-o-y, EBIT EUR 3.1m (2m)
12x-8x '25e-'27e EV/EBIT


Q1 expectations

We expect Cavotec to deliver Q1 sales of EUR 45m, +4% y-o-y and -2% q-o-q. Q4'24 order intake was exceptionally strong for Cavotec, due to several large orders (+52% y-o-y including announced orders, +8% y-o-y excluding). However, we do not fully extrapolate this to Q1e, as order intake tends to fluctuate between quarters and no orders were announced during the quarter. Furthermore, we still expect order intake to grow: we estimate EUR 43m, +7% y-o-y. The company continues to work on its change programme with enhanced cost control, which we expect will yield higher margins y-o-y. For EBIT, we forecast EUR 3.1m for a margin of 6.9% (4.5% in Q1'24).
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.